GUD.TO
Knight Therapeutics Inc
Price:  
5.72 
CAD
Volume:  
27,100.00
Canada | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GUD.TO EV/EBITDA

-7.1%
Upside

As of 2024-07-16, the EV/EBITDA ratio of Knight Therapeutics Inc (GUD.TO) is 9.85. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GUD.TO's latest enterprise value is 586.85 mil CAD. GUD.TO's TTM EBITDA according to its financial statements is 59.56 mil CAD. Dividing these 2 quantities gives us the above GUD.TO EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 6.8x - 9.9x 8.4x
Forward P/E multiples 6.6x - 6.8x 6.7x
Fair Price 3.93 - 5.88 5.32
Upside -31.4% - 2.9% -7.1%
5.72 CAD
Stock Price
5.32 CAD
Fair Price

GUD.TO EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-07-15 10.09
2024-07-12 9.85
2024-07-11 9.92
2024-07-10 9.72
2024-07-09 9.62
2024-07-08 9.85
2024-07-05 9.80
2024-07-04 9.80
2024-07-03 9.90
2024-07-02 9.85
2024-06-28 9.77
2024-06-27 9.65
2024-06-26 9.45
2024-06-25 9.41
2024-06-24 9.38
2024-06-21 9.36
2024-06-20 9.33
2024-06-19 9.39
2024-06-18 9.36
2024-06-17 9.48
2024-06-14 9.82
2024-06-13 9.89
2024-06-12 10.09
2024-06-11 9.89
2024-06-10 10.01
2024-06-07 10.09
2024-06-06 10.11
2024-06-05 10.11
2024-06-04 9.87
2024-06-03 10.11
2024-05-31 10.33
2024-05-30 9.97
2024-05-29 10.35
2024-05-28 10.21
2024-05-27 10.33
2024-05-24 10.33
2024-05-23 10.26
2024-05-22 10.33
2024-05-21 10.45
2024-05-17 10.52
2024-05-16 10.57
2024-05-15 10.50
2024-05-14 10.59
2024-05-13 10.42
2024-05-10 10.23
2024-05-09 10.50
2024-05-08 10.19
2024-05-07 10.11
2024-05-06 10.19
2024-05-03 10.18